The efficacy of vagus nerve stimulation for epilepsy in Malaysia
View abstract on PubMed
Summary
This summary is machine-generated.Vagus nerve stimulation (VNS) effectively reduces seizures in Malaysian patients with refractory epilepsy. Over 70% experienced significant seizure reduction at last follow-up, demonstrating VNS efficacy.
Area Of Science
- Neurology
- Epilepsy Research
- Neurosurgery
Background
- Vagus nerve stimulation (VNS) implantation in Malaysia began in 2000, with a significant increase in procedures since 2019.
- VNS is utilized for epilepsy patients with persistent seizures post-surgery or those unsuitable for surgical intervention.
Purpose Of The Study
- To evaluate the efficacy of vagus nerve stimulation (VNS) in a Malaysian cohort.
- To analyze seizure reduction rates and identify factors influencing VNS effectiveness in refractory epilepsy.
Main Methods
- Retrospective cross-sectional study of VNS procedures in Malaysia from January 2000 to December 2022.
- Inclusion of DRE patients of all ages with at least one year of VNS follow-up data.
Main Results
- 63.3% of patients achieved ≥50% seizure reduction at one year, with 73.5% at last follow-up.
- Optimal VNS parameters included current intensity ≥2mA (98.0%) and duty cycle ≥35% (81.6%).
- No significant differences in response were observed based on age at implantation, epilepsy duration, or seizure type.
Conclusions
- Vagus nerve stimulation (VNS) demonstrates significant efficacy in managing refractory epilepsy in Malaysia.
- Approximately two-thirds of patients achieved substantial seizure reduction, highlighting VNS as a viable treatment option.

